Understanding ADC Charge Variants to Enable Effective CQA Assessment & Control Strategy

2:00 pm - Monday 12th October 2026

  • Understanding the sources and impacts of ADC charge variant profiles given impact from linker payload properties
  • Undergoing CQA assessments to determine ADC clinical relevance
  • Defining compound-specific, phase appropriate and value-focused control strategies

Speakers:

Associate Scientific Director
Bristol Myers Squibb